Protocol to Obtain Blood Samples for Leukemia Research
Status: | Active, not recruiting |
---|---|
Conditions: | Blood Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/8/2019 |
Start Date: | April 2009 |
End Date: | April 2020 |
The purpose of this study is to collect a blood sample in patients with Chronic Lymphocytic
Leukemia (CLL).
Leukemia (CLL).
The blood sample will be used in the laboratory to perform studies focusing on Chronic
Lymphocytic Leukemia (CLL).
Lymphocytic Leukemia (CLL).
Inclusion Criteria:
- Patients undergoing routine blood draws as part of their ongoing follow-up for Chronic
Lymphocytic Leukemia (CLL) at the Norris Cotton Cancer Center of DHMC.
Exclusion Criteria:
- Patients who have received cytotoxic drug, oral or intravenous steroid or targeted
antibody therapy for CLL or other disease process within the past 6 months are
excluded. Use of intravenous immunoglobulin (IVIg) is not a reason for exclusion.
We found this trial at
1
site
1 Medical Center Dr
Lebanon, New Hampshire 03756
Lebanon, New Hampshire 03756
(603) 650-5000
![Dartmouth Hitchcock Medical Center](/wp-content/uploads/logos/dartmouth-hitchcock-medical-center.png)
Principal Investigator: Christopher H Lowrey
Phone: 800-639-6918
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)